• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

68Ga-PSMA-PET/CT 在前列腺癌患者淋巴结覆盖的盆腔放疗野定义中的作用。

Role of 68-Ga-PSMA-PET/CT in pelvic radiotherapy field definitions for lymph node coverage in prostate cancer patients.

机构信息

Department of Radiation Oncology, Adana Dr. Turgut Noyan Research and Treatment Center, Baskent University, Faculty of Medicine, Adana, Turkey.

Department of Radiation Oncology, Hacettepe University, Faculty of Medicine, Ankara, Turkey.

出版信息

Radiother Oncol. 2020 Oct;151:222-227. doi: 10.1016/j.radonc.2020.08.021. Epub 2020 Aug 28.

DOI:10.1016/j.radonc.2020.08.021
PMID:32861704
Abstract

PURPOSE

To evaluate the distribution of metastatic lymph nodes (LN) detected on Ga-PSMA-positron emission tomography/computed tomography (PET/CT) in treatment-naïve prostate cancer (PC) patients and to analyze the LN coverage rates of the pelvic fields defined in the GETUG trial and RTOG guidelines and a pelvic field extending superiorly from the L4/L5 interspace.

MATERIALS AND METHODS

Ga-PSMA-PET/CT images obtained at diagnosis of 138 PC patients were retrospectively analyzed. The number and locations of Ga-PSMA-positive LNs were co-registered with one single-planning CT. The numbers, locations, and sizes of LNs located outside the three pelvic volumes were investigated for the entire cohort and for patients with LN metastasis in the pelvic area only.

RESULTS

A total of 441 PSMA-PET-positive LN metastases were identified. The most frequent metastatic LNs were internal iliac LNs (25.2%). Para-aortic and presacral LNs outside the three pelvic fields were present in 20 (14.5%) and 22 patients (15.9%), respectively. The LN coverage rates according to the GETUG trial, the RTOG guidelines, and the pelvic field extending superiorly from L4/L5 were 44.2%, 52.2%, and 71, respectively, in the entire cohort and 51.7%, 61 and 83.1%, respectively, in patients with only pelvic LN metastasis. The number of metastatic LNs was a predictive factor for LNs located outside the three pelvic fields.

CONCLUSIONS

Extending the cranial margin of the pelvic field from L5/S1 to L4/L5 increases the accuracy of pelvic field irradiation in approximately 20% of patients, highlighting the importance of proximal common iliac irradiation, particularly in patients with multiple LN metastasis.

摘要

目的

评估 Ga-PSMA 正电子发射断层扫描/计算机断层扫描(PET/CT)在未经治疗的前列腺癌(PC)患者中检测到的转移性淋巴结(LN)的分布,并分析 GETUG 试验和 RTOG 指南中定义的骨盆场以及从 L4/L5 间隙向上延伸的骨盆场的 LN 覆盖率。

材料和方法

回顾性分析了 138 例 PC 患者在诊断时获得的 Ga-PSMA-PET/CT 图像。Ga-PSMA 阳性 LN 的数量和位置与单个计划 CT 进行了共配准。研究了整个队列以及仅在盆腔区域有 LN 转移的患者中位于三个盆腔体积之外的 LN 的数量、位置和大小。

结果

共发现 441 个 PSMA-PET 阳性 LN 转移。最常见的转移性 LN 是髂内 LN(25.2%)。在 20 名(14.5%)和 22 名(15.9%)患者中,存在腹主动脉旁和骶前 LN 位于三个骨盆场之外。根据 GETUG 试验、RTOG 指南和从 L4/L5 向上延伸的骨盆场,整个队列的 LN 覆盖率分别为 44.2%、52.2%和 71%,而仅在盆腔 LN 转移的患者中分别为 51.7%、61%和 83.1%。转移性 LN 的数量是位于三个骨盆场之外的 LN 的预测因素。

结论

将骨盆场的颅侧边缘从 L5/S1 延伸到 L4/L5 可使大约 20%的患者骨盆场照射的准确性提高,突出了近端髂总照射的重要性,尤其是在多个 LN 转移的患者中。

相似文献

1
Role of 68-Ga-PSMA-PET/CT in pelvic radiotherapy field definitions for lymph node coverage in prostate cancer patients.68Ga-PSMA-PET/CT 在前列腺癌患者淋巴结覆盖的盆腔放疗野定义中的作用。
Radiother Oncol. 2020 Oct;151:222-227. doi: 10.1016/j.radonc.2020.08.021. Epub 2020 Aug 28.
2
Potential Impact of Ga-PSMA-11 PET/CT on the Planning of Definitive Radiation Therapy for Prostate Cancer.镓-PSMA-11 PET/CT 对前列腺癌根治性放疗计划的潜在影响。
J Nucl Med. 2018 Nov;59(11):1714-1721. doi: 10.2967/jnumed.118.209387. Epub 2018 Apr 13.
3
PSMA-PET/CT-based Lymph Node Atlas for Prostate Cancer Patients Recurring After Primary Treatment: Clinical Implications for Salvage Radiation Therapy.基于 PSMA-PET/CT 的前列腺癌患者原发治疗后复发的淋巴结图谱:挽救性放疗的临床意义。
Eur Urol Oncol. 2021 Feb;4(1):73-83. doi: 10.1016/j.euo.2020.04.004. Epub 2020 May 22.
4
Impact of Ga-PSMA-PET imaging on target volume definition and guidelines in radiation oncology - a patterns of failure analysis in patients with primary diagnosis of prostate cancer.镓-PSMA-PET 成像对放射肿瘤学中靶区定义和指南的影响——前列腺癌初诊患者失败模式分析。
Radiat Oncol. 2018 Mar 1;13(1):36. doi: 10.1186/s13014-018-0977-2.
5
Pelvic lymph node mapping in prostate cancer: examining the impact of PSMA PET/CT on radiotherapy decision-making in patients with node-positive disease.前列腺癌盆腔淋巴结清扫:探讨 PSMA PET/CT 对淋巴结阳性患者放疗决策的影响。
Cancer Imaging. 2024 Jul 29;24(1):96. doi: 10.1186/s40644-024-00742-3.
6
Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography-based Lymph Node Atlas for Salvage Radiotherapy in Patients with Recurrent Prostate Cancer: A Validation of the New NRG Oncology 2020 guideline.基于前列腺特异性膜抗原正电子发射断层扫描/计算机断层扫描的复发性前列腺癌患者挽救性放疗淋巴结图谱:新的NRG肿瘤学2020指南的验证
Eur Urol Oncol. 2022 Dec;5(6):668-676. doi: 10.1016/j.euo.2022.09.006. Epub 2022 Oct 21.
7
Value of 68Ga-PSMA HBED-CC PET for the Assessment of Lymph Node Metastases in Prostate Cancer Patients with Biochemical Recurrence: Comparison with Histopathology After Salvage Lymphadenectomy.68Ga-PSMA HBED-CC PET 对生化复发前列腺癌患者淋巴结转移评估的价值:与挽救性淋巴结切除术后组织病理学的比较。
J Nucl Med. 2016 Nov;57(11):1713-1719. doi: 10.2967/jnumed.116.173492. Epub 2016 Jun 3.
8
Comparison of Ga-PSMA-11 PET-CT with mpMRI for preoperative lymph node staging in patients with intermediate to high-risk prostate cancer.镓-PSMA-11 PET-CT 与 mpMRI 用于中高危前列腺癌患者术前淋巴结分期的比较。
J Transl Med. 2017 Nov 7;15(1):230. doi: 10.1186/s12967-017-1333-2.
9
Mask R-CNN assisted 2.5D object detection pipeline of Ga-PSMA-11 PET/CT-positive metastatic pelvic lymph node after radical prostatectomy from solely CT imaging.基于 Ga-PSMA-11 PET/CT 阳性的前列腺癌根治术后转移盆腔淋巴结的 CT 影像,采用 Mask R-CNN 辅助的 2.5D 目标检测方法。
Sci Rep. 2023 Jan 30;13(1):1696. doi: 10.1038/s41598-023-28669-y.
10
Patterns of Lymph Node Failure after Dose-escalated Radiotherapy: Implications for Extended Pelvic Lymph Node Coverage.剂量递增放疗后淋巴结失败模式:对扩大盆腔淋巴结覆盖范围的意义。
Eur Urol. 2017 Jan;71(1):37-43. doi: 10.1016/j.eururo.2016.07.043. Epub 2016 Aug 11.

引用本文的文献

1
National survey of radiotherapy and androgen deprivation therapy strategies with PSMA-PET/CT integration in intermediate-risk prostate cancer: TROD 09-007 study.PSMA-PET/CT 融合在中危前列腺癌放疗和雄激素剥夺治疗策略中的全国性调查:TROD 09-007 研究
Can J Urol. 2025 Aug 29;32(4):243-254. doi: 10.32604/cju.2025.066700.
2
Propensity Score Matched Analysis of External Beam Radiotherapy With or Without Focal Boost to Intraprostatic Lesions in Prostate Cancer.前列腺癌中对前列腺内病变进行或不进行局部加量的外照射放疗的倾向评分匹配分析。
Prostate. 2025 Jun;85(8):805-813. doi: 10.1002/pros.24888. Epub 2025 Mar 11.
3
Letter to the editor concerning 'Whole pelvis vs. hemi pelvis elective nodal radiotherapy in patients with PSMA-positive nodal recurrence after radical prostatectomy - a retrospective multi-institutional propensity score analysis.'.
致编辑的信:关于“根治性前列腺切除术后PSMA阳性淋巴结复发患者全盆腔与半盆腔选择性淋巴结放疗——一项回顾性多机构倾向评分分析”
Eur J Nucl Med Mol Imaging. 2024 Oct;51(12):3785-3786. doi: 10.1007/s00259-024-06876-7. Epub 2024 Aug 19.
4
The significance of metabolic response to neoadjuvant androgen deprivation therapy detected with [Ga]Ga-PSMA-11-PET/CT in high-risk prostate cancer patients treated with definitive radiotherapy.在接受根治性放疗的高危前列腺癌患者中,用[镓]镓-PSMA-11-PET/CT检测新辅助雄激素剥夺治疗的代谢反应的意义。
Eur J Nucl Med Mol Imaging. 2023 Oct;50(12):3755-3764. doi: 10.1007/s00259-023-06321-1. Epub 2023 Jul 5.
5
The Sentinel Lymph Node in Treatment Planning: A Narrative Review of Lymph-Flow-Guided Radiotherapy.治疗计划中的前哨淋巴结:淋巴引流引导放疗的叙述性综述
Cancers (Basel). 2023 May 12;15(10):2736. doi: 10.3390/cancers15102736.
6
The addition of androgen deprivation therapy and pelvic lymph node treatment to prostate bed salvage radiotherapy (NRG Oncology/RTOG 0534 SPPORT): an international, multicentre, randomised phase 3 trial.雄激素剥夺治疗和盆腔淋巴结治疗联合前列腺床挽救性放疗(NRG Oncology/RTOG 0534 SPORT):一项国际、多中心、随机 3 期试验。
Lancet. 2022 May 14;399(10338):1886-1901. doi: 10.1016/S0140-6736(21)01790-6.
7
Incorporating PSMA-Targeting Theranostics Into Personalized Prostate Cancer Treatment: a Multidisciplinary Perspective.将靶向前列腺特异性膜抗原(PSMA)的诊疗一体化技术纳入前列腺癌个性化治疗:多学科视角
Front Oncol. 2021 Jul 28;11:722277. doi: 10.3389/fonc.2021.722277. eCollection 2021.
8
Stereotactic radiotherapy to oligoprogressive lesions detected with Ga-PSMA-PET/CT in castration-resistant prostate cancer patients.镓-PSMA-PET/CT 检测到寡进展性病变的局限性前列腺癌患者的立体定向放疗。
Eur J Nucl Med Mol Imaging. 2021 Oct;48(11):3683-3692. doi: 10.1007/s00259-021-05298-z. Epub 2021 Mar 10.